[1]
H. S.Yousif and Y. I. Khalil, “Some Variables Affecting the Formulation of Oral Loratadine Suspension”, Iraqi Journal of Pharmaceutical Sciences , vol. 17, no. 2, pp. 18–25, Mar. 2017, doi: 10.31351/vol17iss2pp18-25.